Experts say the approach could also save millions of pounds by cutting projects or clinical trials that would otherwise fail.

In its annual 'Measuring the Return from Pharmaceutical Innovation' report based on the top 20 pharma companies by 2020 R&D ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...

Thousands of 3D protein structures locked up in big-pharma vaults will be used to create a new AI tool that won’t be open to ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

Here's the problem: The cost of developing new drugs and getting them approved typically exceeds $2 billion -- and takes ...

Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study ...

Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could ...

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

Commonsense management measures can help keep arthritic horses comfortable and sound even in the coldest weather.

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies ...